Inicio>>Signaling Pathways>> Others>>ONO 2506

ONO 2506 (Synonyms: ONO-2506)

Catalog No.GC10652

El Ácido arÚndico (ONO-2506) es un agente modulador de astrocitos, que retrasa la expansiÓn de los infartos cerebrales al modular la activaciÓn de los astrocitos a través de la inhibiciÓn de S-100β sÍntesis.

Products are for research use only. Not for human use. We do not sell to patients.

ONO 2506 Chemical Structure

Cas No.: 185517-21-9

Tamaño Precio Disponibilidad Cantidad
10mM (in 1mL DMSO)
46,00 $
Disponible
10mg
102,00 $
Disponible
25mg
167,00 $
Disponible
50mg
260,00 $
Disponible
100mg
464,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Product has been cited by 2 publications

Description Chemical Properties Product Documents Related Products

Arundic acid (ONO-2506) is an astrocyte-modulating agent, which delays the expansion of cerebral infarcts by modulating the activation of astrocytes through inhibition of S-100β synthesis. Arundic acid (ONO-2506) has been developed as a therapeutic agent for stroke and Alzheimer’s disease[1][2][3].

References:
[1]. Tomoyuki Hasegawa, et al. Process Development of ONO-2506:  A Therapeutic Agent for Stroke and Alzheimer's Disease. Org. Process Res. Dev.200372168-171.
[2]. Kato H, et al. Arundic acid, an astrocyte-modulating agent, protects dopaminergic neurons against MPTPneurotoxicity in mice. Brain Res. 2004 Dec 24;1030(1):66-73.

Reseñas

Review for ONO 2506

Average Rating: 5 ★★★★★ (Based on Reviews and 3 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for ONO 2506

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.